Clinical Trial

Phase II Clinical Study of VC005 Tablets in Subjects With Severe Alopecia Areata

Name: Phase II Clinical Study of VC005 Tablets in Subjects With Severe Alopecia Areata — clinical trial record (NCT07749716)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This study is a multicenter, randomized, double-blind, placebo-controlled Phase II clinical study designed to evaluate the efficacy and safety of VC005 tablets in subjects with severe alopecia areata (AA).

Trial Details

NCT Number	NCT07749716
Lead Sponsor	Jiangsu vcare pharmaceutical technology co., LTD
Conditions	Alopecia Areata
Enrollment	120 participants
Start Date	2026-08-15
Primary Completion	2028-12-30 (estimated)
Study Completion	2028-12-30 (estimated)
Updated on ClinicalTrials.gov	2026-08-06